Thursday, Jul 10, 2025
logo
Update At 18:00    USD/JPY 146,67  ↑+0.074        EUR/JPY 171,79  ↓-0.083        GBP/JPY 199,47  ↑+0.279        USD/EUR 1,17  ↓-0.0006        USD/KRW 1.376,47  ↑+6.6699        JPY/SGD 0,01  ↑+0        Germany: DAX 45,33  ↑+0.55        Spain: IBEX 35 30,30  ↓-0.16        France: CAC 40 43,34  ↑+0.31        Nasdaq, Inc. 88,59  ↓-1.96        SPDR S&P 500 ETF Trust 620,34  ↓-0.34        Gold 3.285,21  ↓-15.82        Bitcoin 108.676,52  ↓-281.52        Ethereum 2.614,38  ↑+0.44        

Shimadzu Diagnostics: pioneering development in regenerative medicine and microbial testing

Flag USAFlag JAPAN
Article - September 5, 2023

Through its microbial testing kits and regenerative medicine solutions, Shimadzu Diagnostics is helping to tackle the greatest global health challenges.

COMPACTDRY

Following its establishment in 1935, Nissui Pharmaceutical sourced marine-based ingredients for medicinal and pharmaceutical purposes. Today, the company – which was renamed Shimadzu Diagnostics Corporation in April following its 100% takeover by Shimadzu Corporation – is a leader in the field of microbial testing kits and regenerative medicine solutions.

The emergence of new strains of bacteria is one of the most serious global health challenges. To tackle this issue, tracing where the resistant strains come from and identifying the root causes for resistance is of paramount importance. In response, Nissui developed Raisus S4, a fully automated rapid bacteria identification and antimicrobial susceptibility testing instrument using digital detection technology. 



Another of the company’s flagship microbial testing kits is Compact Dry, a ready-to-use culture media that is used in the detection of bacteria strains and the potential causes for food poisoning. “While other culture media require chilling between 2-5°C, CompactDry is a dry medium that can be transported without such precautions,” explains company president Tokuya Ono.

With Japan leading the way in regenerative medicine, Shimadzu Diagnostics is supporting the fast-growing medical field with cell culture medium and testing solutions, including HYDROX, a three-dimensional cell culture substrate that allows the growth of different types of cells, and MSF-BM, a high-quality cell culture medium. “Since the cell culture business, particularly culture media and reagents, is part of our rich know-how, our strategy is to provide custom-made solutions in this field,” says Mr. Ono.

COMPANY DATABASESee all Database >

TSUKASA PETCO CORPORATION

Manufacturing, Japan

Clean Chemical Co., Ltd.

Manufacturing, Japan

LIKE, Inc.

Education, Japan

LEADER DATABASESee all Database >

Eishi Morita

President and CEO
TSUKASA PETCO CORPORATION

Shozo Yano

President
Clean Chemical Co., Ltd.

Naoki Kashiwagi

President
Yamafuku Co., Ltd.

Wataru Shigemori

President
Kensetsu System Co., ltd.

  0 COMMENTS